help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARIE, C.
Right arrow Articles by CAVAILLON, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MARIE, C.
Right arrow Articles by CAVAILLON, J.-M.

Am. J. Respir. Crit. Care Med., Volume 156, Number 5, November 1997, 1515-1522

Cytokines and Soluble Cytokine Receptors in Pleural Effusions from Septic and Nonseptic Patients

CHRISTELLE MARIE, MARIE-REINE LOSSER, CATHERINE FITTING, NATHALIE KERMARREC, DIDIER PAYEN, and JEAN-MARC CAVAILLON

Unité d'Immuno-Allergie, Institut Pasteur; and Department of Anaesthesia and Intensive Care Unit, Hôpital Lariboisière, Paris, France

The balance between proinflammatory cytokines and their inhibitors has rarely been investigated in pleural effusions of nonmalignant or noninfectious origin. To evaluate the impact of a lung and/or intrathoracic infection in such a circumstance, we compared the levels of proinflammatory cytokines (interleukin-8 [IL-8]); tumor necrosis factor-alpha (TNF-alpha ); the cytokine antagonists and inhibitors (IL-1 receptor antagonist [IL-1ra] ) and soluble TNF receptors Types I and II (sTNFRI, sTNFRII); and antiinflammatory cytokines (transforming growth factor-beta [TGF-beta ]) in pleural effusion and plasma from septic (n = 15) and nonseptic (n = 9) patients. In addition, we analyzed the levels of IL-6 and its soluble receptor (sIL-6R). Bronchoalveolar lavage fluids (BALFs) were also studied in a few septic patients. High and nonsignificantly different levels of cytokines and inhibitors were detected in both groups of patients. The levels of IL-6 and sTNFRI and sTNFRII in pleural effusion were higher than in plasma, whereas the levels of IL-1ra and sIL-6R were higher in plasma. The levels of sIL-6R influenced the bioactivity of IL-6. There was no correlation between the levels of cytokines in plasma and in pleural effusion. In contrast, a significant correlation was observed for the soluble receptors sIL-6R (r = 0.67, p < 0.001), sTNFRI (r = 0.76, p < 0.001) and sTNFRII (r = 0.66, p = 0.001). Furthermore, a high correlation was found between the levels of both forms of sTNFRs in plasma (r = 0.95, p < 0.001) and in pleural effusion (r = 0.79, p < 0.001). In addition, a correlation was observed between the levels of TGF-beta in pleural effusion and in BALF. The highest levels of some markers in plasma and of others in pleura argue in favor of both a systemic and a compartmentalized response, independently of the presence of infection. Because cytokines can be trapped by the surrounding cells in their environment, measurable levels of cytokines in biologic fluids represent the "tip of the iceberg," which is not the case for soluble receptors. The correlations of these latter markers between plasma and pleura strongly suggest that exchanges between both compartments can occur in both directions.




This article has been cited by other articles:


Home page
Innate ImmunityHome page
J.-M. Cavaillon and D. Annane
Invited review: Compartmentalization of the inflammatory response in sepsis and SIRS
Innate Immunity, June 1, 2006; 12(3): 151 - 170.
[Abstract] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
T. Weiss, I. Shalit, H. Blau, S. Werber, D. Halperin, A. Levitov, and I. Fabian
Anti-Inflammatory Effects of Moxifloxacin on Activated Human Monocytic Cells: Inhibition of NF-{kappa}B and Mitogen-Activated Protein Kinase Activation and of Synthesis of Proinflammatory Cytokines
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 1974 - 1982.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. M. Porcel, M. Vives, and A. Esquerda
Tumor Necrosis Factor-{alpha} in Pleural Fluid: A Marker of Complicated Parapneumonic Effusions
Chest, January 1, 2004; 125(1): 160 - 164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. A. Sasse, M. R. Jadus, and G. D. Kukes
Pleural Fluid Transforming Growth Factor-{beta}1 Correlates with Pleural Fibrosis in Experimental Empyema
Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 700 - 705.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D H Strong, J Y Westcott, J A Biller, J L Morrison, R M Effros, and J P Maloney
Eosinophilic "empyema" associated with crack cocaine use
Thorax, September 1, 2003; 58(9): 823 - 824.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
J.-M. Cavaillon, M. Adib-Conquy, I. Cloez-Tayarani, and C. Fitting
Review: Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review
Innate Immunity, April 1, 2001; 7(2): 85 - 93.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
S. J. Ebong, S. M. Goyert, J. A. Nemzek, J. Kim, G. L. Bolgos, and D. G. Remick
Critical Role of CD14 for Production of Proinflammatory Cytokines and Cytokine Inhibitors during Sepsis with Failure To Alter Morbidity or Mortality
Infect. Immun., April 1, 2001; 69(4): 2099 - 2106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. S. MUNFORD and J. PUGIN
Normal Responses to Injury Prevent Systemic Inflammation and Can Be Immunosuppressive
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 316 - 321.
[Full Text]


Home page
ChestHome page
D.-s. Cheng, Y. C. G. Lee, J. T. Rogers, E. A. Perkett, J. P. Moyers, R. M. Rodriguez, and R. W. Light
Vascular Endothelial Growth Factor Level Correlates With Transforming Growth Factor-{beta} Isoform Levels in Pleural Effusions
Chest, December 1, 2000; 118(6): 1747 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Yamaguchi, H. Kimura, S. Yokota, Y. Yamamoto, T. Hashimoto, M. Nakagawa, M. Ito, and T. Ogura
Effect of IL-6 Elevation in Malignant Pleural Effusion on Hyperfibrinogenemia in Lung Cancer Patients
Jpn. J. Clin. Oncol., February 1, 2000; 30(2): 53 - 58.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society
  Tobacco